Li, C-J <br/><br/>
Efficacy and safety comparison of add-on therapy with liraglutide, saxagliptin and vildagliptin, all in combination with current conventional oral hypoglycemic agents therapy in poorly controlled Chinese type 2 diabetes.  [electronic resource] 

 -  Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association  Sep 2014 
 - 469-76 p.  digital 
<br/><br/> Publication Type: Journal Article; Randomized Controlled Trial 
<br/><br/><label>ISSN: </label>1439-3646 
<br/><br/><label>Standard No.: </label>10.1055/s-0034-1374586  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adamantane--adverse effects<br/>Adult<br/>Asian People<br/>Blood Glucose<br/>Body Weight<br/>China<br/>Diabetes Mellitus, Type 2--drug therapy<br/>Dipeptides--adverse effects<br/>Drug Therapy, Combination<br/>Female<br/>Glucagon-Like Peptide 1--adverse effects<br/>Humans<br/>Hypoglycemic Agents--adverse effects<br/>Insulin--therapeutic use<br/>Liraglutide<br/>Male<br/>Metformin--therapeutic use<br/>Middle Aged<br/>Nitriles--adverse effects<br/>Pyrrolidines--adverse effects<br/>Treatment Outcome<br/>Vildagliptin